Meet Seth Whitelaw
Director, Deloitte & Touche LLP
Seth Whitelaw is a director in Deloitte & Touche LLP’s Governance, Regulatory and Risk Strategies practice.
He has more than 20 years of experience in the life sciences and healthcare industries in the areas of food and drug law, as well as corporate governance and compliance for medical devices, pharmaceutical sales and marketing, and pharmaceutical research and development.
Prior to joining Deloitte, Seth served as legal compliance officer for two different major pharmaceutical companies and was a senior attorney and compliance coordinator for a major medical technologies company. In the latter role, Seth was responsible for implementing and managing the company’s global compliance program and advising on various food and drug matters. He was a Food and Drug Law Institute Fellow and served as an intern with the Food and Drug Administration’s Office of Chief Counsel.
Seth is a member of the New York State Bar Association and several industry associations. Seth holds law degrees from the Washington & Lee University School of Law (J.D.), GWU Law School (LL.M.) and Widener University School of Law (S.J.D.). He is licensed to practice law in the Commonwealths of Virginia and Pennsylvania.
As used on this page, “Deloitte” means Deloitte & Touche LLP, a subsidiary of Deloitte LLP, Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting.